News

ASCO 2013: Breast cancer research highlights

Publish date: June 5, 2013

 

Dr. William Gradishar and Dr. Hope Rugo, Associate Editors of The Oncology Report, give their perspectives on how new breast cancer research presented at ASCO 2013 should affect clinical practice.

Recommended Reading

Finding the metastatic needle in the haystack
MDedge Hematology and Oncology
Oral HPV-related cancer risk not transmitted to sex partners
MDedge Hematology and Oncology
Maintenance pazopanib delays progression of advanced ovarian cancer
MDedge Hematology and Oncology
Cervical cancer screening with acetic acid saves lives
MDedge Hematology and Oncology
Bevacizumab plus chemotherapy extends cervical cancer survival
MDedge Hematology and Oncology
10 years of tamoxifen halves risk of death from breast cancer
MDedge Hematology and Oncology
Which paclitaxel schedule works best for breast cancer?
MDedge Hematology and Oncology
Palbociclib continues on fast track to potential FDA approval
MDedge Hematology and Oncology
Study confirms benefits of 10 years of tamoxifen
MDedge Hematology and Oncology
Weekly adjuvant paclitaxel for breast cancer has less toxicity
MDedge Hematology and Oncology